Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Survodutide (BI 456906) is a GLP-1R/GCGR dual agonist developed by Boehringer Ingelheim, with outcomes of a phase 2 trial in MASLD and a phase 1 trial in cirrhosis published almost simultaneously with tirzepatide
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning
When using GLP-1 medications for weight loss, keeping track of certain health metrics is crucial to ensure youre progressing safely and effectively
L-carnitine and acetylcarnitine in research subjects sperm with normal and reduced [PMID: 3630566] Laboratory literature summary: L-carnitine and acetylcarnitine in research subjects sperm with normal and reduced motility
View Current Batch COA - (June 2026) Quantity discounts How Does It Work Retatrutide: tri-agonist peptide Retatrutide is a tri-agonist peptide that engages GLP-1, GIP, and glucagon receptors
US$ 27.07
.png?sfvrsn=1e7191c0_3)
US$ 28.71
:max_bytes(150000):strip_icc()/GettyImages-1807240274-2c7c39cb23f34a97bb2d8620911c343d.jpg)
US$ 27.83
US$ 20.60
